Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;66(5):580-581.
doi: 10.1165/rcmb.2021-0369LE.

Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform

Claudia Mickael  1 , Vitaly O Kheyfets  1 , Christophe Langouët-Astrié  1 , Michael H Lee  2 , Linda A Sanders  1 , Caio O Trentin  1 , Andrew J Sweatt  3 , Roham T Zamanian  3 , Todd M Bull  1 , Kurt Stenmark  1 , Brian B Graham  2 , Rubin M Tuder  1
Affiliations

Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform

Claudia Mickael et al. Am J Respir Cell Mol Biol. 2022 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Heatmap of the 20 inflammation markers differentially expressed in control subjects (CTL), subjects with idiopathic pulmonary arterial hypertension (IPAH), and subjects with scleroderma-associated pulmonary arterial hypertension (SSc-PAH), clustered by proteins and subjects (z-scores).
See this image and copyright information in PMC

References

    1. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res . 2014;115:165–175. - PMC - PubMed
    1. Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol . 2015;308:L229–L252. - PMC - PubMed
    1. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol . 2009;78:539–552. - PMC - PubMed
    1. Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res . 2017;367:643–649. - PMC - PubMed
    1. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med . 2012;186:261–272. - PMC - PubMed

Publication types